1134.Hk
1134.HK operates in the healthcare services and equipment sector, primarily engaged in the distribution of medical equipment and supplies.
Business. 1134.HK operates in the healthcare services and equipment sector, primarily engaged in the distribution of medical equipment and supplies.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
1134.HK operates in the healthcare services and equipment sector, primarily engaged in the distribution of medical equipment and supplies.
The company's capital structure is characterized by a low debt-to-equity ratio of 0.06, indicating a conservative leverage position. However, the current ratio of 1.91 suggests moderate liquidity, with the company holding sufficient current assets to cover its short-term liabilities. Despite this, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints.
Profitability metrics reveal a challenging financial position. The company reported a net loss of HKD 15.12 million, with a return on equity of -10.18% and a return on assets of -5.35%. These figures are significantly below the industry median for profitability, indicating underperformance relative to its peers. The operating loss of HKD 11.09 million further underscores the company's struggle to generate sustainable earnings.
The company's revenue is not segmented by geographic region or product line in the available data, making it difficult to assess the concentration of its revenue streams. However, the lack of detailed segment reporting suggests a potential overreliance on a single market or product category, which could pose a risk to its long-term stability.
Looking ahead, the company's growth trajectory is uncertain. The absence of specific revenue growth projections and the current financial losses indicate a lack of clear momentum. Historical revenue data does not provide a strong basis for optimism, and without significant operational improvements or strategic shifts, the company may continue to face financial challenges.
The risk assessment highlights several concerns. The company's liquidity is rated as medium, and while dilution risk is currently low, the negative net cash position and operating losses could necessitate future equity or debt financing. Any such financing would likely involve dilution, particularly if the company issues new shares to raise capital. The absence of detailed dilution sources in the available data means that the potential for dilution remains speculative.
Recent events and filings do not provide specific details on the company's strategic direction or operational changes. The lack of recent transcripts or detailed filings suggests limited transparency, which could be a concern for investors seeking to understand the company's future plans and risk profile.
- The company is operating at a net loss with negative returns on equity and assets, indicating poor profitability.
- The company's capital structure is relatively conservative, with a low debt-to-equity ratio, but its liquidity position is only moderate.
- The lack of detailed segment and geographic revenue data makes it difficult to assess the company's exposure to specific markets or products.
- The company's growth trajectory is uncertain, with no clear signs of improvement in its financial performance.
- The risk of future dilution exists due to the company's negative net cash position and operating losses, though it is currently rated as low.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Return On Assetsnet_income / total_assets
- 1134.HK Market data — financials · 2026-05-26
Ownership & reference
Leadership
- Joe KwokExecutive Chairman of the Board
- Ken KwokChief Executive Officer, Executive Director